title: Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG.
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA Department of Epidemiology, University of Washington, Seattle, WA, USA rwalter@fredhutch.org.
authors.forename: Roland B
authors.initials: RB
authors.lastname: Walter
authors.affiliation: SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
authors.forename: Megan
authors.initials: M
authors.lastname: Othus
authors.affiliation: Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
authors.forename: Bob
authors.initials: B
authors.lastname: Löwenberg
authors.affiliation: Division of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
authors.forename: Gert J
authors.initials: GJ
authors.lastname: Ossenkoppele
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
authors.forename: Stephen H
authors.initials: SH
authors.lastname: Petersdorf
authors.affiliation: Department of Medical Oncology, University Hospital, Bern, Switzerland.
authors.forename: Thomas
authors.initials: T
authors.lastname: Pabst
authors.affiliation: Department of Hematology, Cliniques Universitaires Saint-Luc UCL, Brussels, Belgium.
authors.forename: Marie-Christiane
authors.initials: MC
authors.lastname: Vekemans
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
authors.forename: Frederick R
authors.initials: FR
authors.lastname: Appelbaum
authors.affiliation: Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.
authors.forename: Harry P
authors.initials: HP
authors.lastname: Erba
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.
authors.forename: Elihu H
authors.initials: EH
authors.lastname: Estey
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000592:standards*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology*; D012008:Recurrence; D012074:Remission Induction; D016896:Treatment Outcome
keywords: acute myeloid leukemia; clinical trials; eligibility criteria; refractory; relapsed